MENU
+Compare
BIIB
Stock ticker: NASDAQ
AS OF
Nov 13, 04:59 PM (EDT)
Price
$164.91
Change
+$3.43 (+2.12%)
Capitalization
23.69B

BIIB Biogen Forecast, Technical & Fundamental Analysis

Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan... Show more

Industry: #Biotechnology
BIIB
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for BIIB with price predictions
Nov 12, 2025

Momentum Indicator for BIIB turns positive, indicating new upward trend

BIIB saw its Momentum Indicator move above the 0 level on October 23, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 87 similar instances where the indicator turned positive. In of the 87 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for BIIB just turned positive on October 31, 2025. Looking at past instances where BIIB's MACD turned positive, the stock continued to rise in of 60 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BIIB advanced for three days, in of 265 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 8 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BIIB declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

BIIB broke above its upper Bollinger Band on November 11, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for BIIB entered a downward trend on November 10, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BIIB’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.301) is normal, around the industry mean (9.612). P/E Ratio (14.720) is within average values for comparable stocks, (23.835). Projected Growth (PEG Ratio) (4.346) is also within normal values, averaging (2.037). BIIB has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.028). P/S Ratio (2.350) is also within normal values, averaging (3.560).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BIIB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 76, placing this stock worse than average.

View a ticker or compare two or three
BIIB
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

BIIB is expected to report earnings to fall 61.12% to $1.87 per share on January 29

Biogen BIIB Stock Earnings Reports
Q4'25
Est.
$1.87
Q3'25
Beat
by $0.93
Q2'25
Beat
by $1.48
Q1'25
Beat
by $0.06
Q4'24
Beat
by $0.03
The last earnings report on October 30 showed earnings per share of $4.81, beating the estimate of $3.88. With 1.23M shares outstanding, the current market capitalization sits at 23.69B.
A.I. Advisor
published General Information

General Information

a manufacturer of therapies for people living with neurological, autoimmune and hematologic disorders

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Biotechnology
Address
225 Binney Street
Phone
+1 617 679-2000
Employees
7570
Web
https://www.biogen.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPDG40.510.31
+0.78%
State Street SPDR PortS&PSectNetrlDivETF
IROC50.940.03
+0.05%
Invesco Rochester High Yield Municipal ETF
EIPX26.90-0.05
-0.17%
FT Energy Income Partners Strategy ETF
TDTT24.18-0.05
-0.21%
FlexShares iBoxx 3Yr Target Dur TIPS ETF
CNBS26.27-0.72
-2.68%
Amplify Seymour Cannabis ETF

BIIB and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, BIIB has been loosely correlated with PFE. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if BIIB jumps, then PFE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIIB
1D Price
Change %
BIIB100%
+1.20%
PFE - BIIB
65%
Loosely correlated
+1.41%
AMGN - BIIB
60%
Loosely correlated
-0.64%
MRK - BIIB
54%
Loosely correlated
+0.55%
BMY - BIIB
53%
Loosely correlated
+0.74%
AZN - BIIB
50%
Loosely correlated
-1.58%
More